FOLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Folex, and when can generic versions of Folex launch?
Folex is a drug marketed by Pharmacia And Upjohn and is included in four NDAs.
The generic ingredient in FOLEX is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Folex
A generic version of FOLEX was approved as methotrexate sodium by HIKMA on September 16th, 1986.
Summary for FOLEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Patent Applications: | 4,463 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FOLEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FOLEX
US Patents and Regulatory Information for FOLEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 087695-001 | Apr 8, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 088954-001 | Oct 24, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | FOLEX | methotrexate sodium | INJECTABLE;INJECTION | 087695-002 | Apr 8, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |